About Solute carrier family 68 member 1
Solute carrier family 68 member 1 (SLC68A1) is a protein
from Homo sapiens identified by UniProt accession
Q14CX5, 517 residues long.
MolForge cross-references it against 0 known binders and
50 disease associations.
Target properties
| Protein name | Solute carrier family 68 member 1 |
| UniProt accession | Q14CX5 |
| Gene | SLC68A1 |
| Organism | Homo sapiens |
| Length | 517 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (50)
Diseases linked to this target (Open Targets).
- platelet crit · score 0.26
- risk-taking behaviour · score 0.25
- leukocyte count · score 0.24
- neutrophil count · score 0.19
- mean corpuscular hemoglobin concentration · score 0.18
- insomnia · score 0.17
- allergic rhinitis · score 0.14
- platelet count · score 0.13
- myeloid white cell count · score 0.13
- alkaline phosphatase measurement · score 0.13
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14CX5-F1 | alphafold | PREDICTED | 81.68 | — |
Amino-acid sequence (517 residues)
MGLGQPQAWL LGLPTAVVYG SLALFTTILH NVFLLYYVDT FVSVYKINKM AFWVGETVFL LWNSLNDPLF GWLSDRQFLS SQPRSGAGLS SRAVVLARVQ ALGWHGPLLA LSFLAFWVPW APAGLQFLLC LCLYDGFLTL VDLHHHALLA DLALSAHDRT HLNFYCSLFS AAGSLSVFAS YAFWNKEDFS SFRAFCVTLA VSSGLGFLGA TQLLRRRVEA ARKDPGCSGL VVDSGLCGEE LLVGSEEADS ITLGRYLRQL ARHRNFLWFV SMDLVQVFHC HFNSNFFPLF LEHLLSDHIS LSTGSILLGL SYVAPHLNNL YFLSLCRRWG VYAVVRGLFL LKLGLSLLML LAGPDHLSLL CLFIASNRVF TEGTCKLLTL VVTDLVDEDL VLNHRKQAAS ALLFGMVALV TKPGQTFAPL LGTWLLCFYT GHDLFQQSLI TPVGSAHPWP EPPAPAPAQA PTLRQGCFYL LVLVPITCAL LQLFTWSQFT LHGRRLHMVK AQRQNLSQAQ TLDVKMV
Explore Solute carrier family 68 member 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets